Physician

Radiation Oncology

Dr. Deborah E. Citrin, MD

Dr. Deborah E. Citrin works in the field of Radiation Oncology. Deborah Citrin is a published physician. He published 61 publications, including: 'Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.'

Publications

Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.
Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.
Transforming Growth Factor Alpha is a Critical Mediator of Radiation Lung Injury.
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer.
Biomarkers to guide therapy or surveillance for prostate cancer.
Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?
Quercetin inhibits radiation-induced skin fibrosis.
Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation.
MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands.
Upregulation of ?-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotectiv...
Localization of Sclerotic-type Chronic Graft-vs-Host Disease to Sites of Skin Injury: Potential Insight Into the Mechanism of Isomorphic and Isotopic Responses.
Enhancement of 5- Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition.
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy.
Surgical management of melanoma brain metastases in patients treated with immunotherapy.
CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin.
Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation.
A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species.
Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.
The legacy of cancer therapy in children.
Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related produ...
Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems.
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
Implications for tumor control during protection of normal tissues with antioxidants.
The role of radiation therapy in the management of sarcomas.
Accuracy of 3D volumetric image registration based on CT, MR and PET/CT phantom experiments.
Optical imaging of mice in oncologic research.
A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal maligna...
In vivo tumor imaging in mice with near-infrared labeled endostatin.
Correction of motion-induced misalignment in co-registered PET/CT and MRI (T1/T2/FLAIR) head images for stereotactic radiosurgery.
Quantitative prediction of respiratory tidal volume based on the external torso volume change: a potential volumetric surrogate.
A novel analytical approach to the prediction of respiratory diaphragm motion based on external torso volume change.
Advancement of antiangiogenic and vascular disrupting agents combined with radiation.
Radioprotectors and mitigators of radiation-induced normal tissue injury.
Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Urine analysis and protein networking identify met as a marker of metastatic prostate cancer.
In vivo tumor imaging using a near-infrared-labeled endostatin molecule.
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer.
Craniospinal irradiation with spinal IMRT to improve target homogeneity.
A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors.
Advances in 4D medical imaging and 4D radiation therapy.
Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.
Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.
Biomarkers in radiation oncology.
Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.
A pilot feasibility study of TNFeradeâ¢ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.
Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation.
In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.
A dosimetric comparison of four treatment planning methods for high grade glioma.
In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.
Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens.
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachyther...
Clinical biomarkers of angiogenesis inhibition.
Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens.
Evaluation of the fullerene compound DF-1 as a radiation protector.

Schools

Duke University

Doctors Specialties

Radiation Oncology

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. David T. Padro, DO
	Dr. Stephen L. Lewis, MD
	Dr. Rex A. Kiteley II, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer C. Jones, MD
	Dr. Christine J. Ko, MD This Doctor is OpenDoctor Recommended.
	Dr. Deedee K. Smart, MD This Doctor is OpenDoctor Recommended.
	Dr. Anatoly B. Dritschilo, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan F. Stinson, MD This Doctor is OpenDoctor Recommended.